Utility of PET/neck MRI digital fusion images in the management of recurrent or persistent thyroid cancer.
暂无分享,去创建一个
Leonard Wartofsky | Frank Atkins | J. Jonklaas | D. van Nostrand | F. Atkins | K. Burman | L. Wartofsky | Jacqueline Jonklaas | Yasser Ousman | Laura Seiboth | Douglas Van Nostrand | Calvin Butler | Kenneth Burman | Laura A. Seiboth | C. Butler | Yasser Ousman | D. Van Nostrand | Calvin Butler
[1] S. Jhiang,et al. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. , 1994, The American journal of medicine.
[2] P. Ladenson,et al. Prospective multicenter study of thyroiscarcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group. , 1998, Cancer.
[3] Louise Davies,et al. Increasing incidence of thyroid cancer in the United States, 1973-2002. , 2006, JAMA.
[4] L. Wartofsky. Using baseline and recombinant human TSH-stimulated Tg measurements to manage thyroid cancer without diagnostic (131)I scanning. , 2002, The Journal of clinical endocrinology and metabolism.
[5] J. Shah,et al. Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996 , 2000, Cancer.
[6] R. Kloos,et al. The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society CLINICAL REVIEW 128 Current Approaches to Primary Therapy for Papillary , 2022 .
[7] O. Schober,et al. Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicentre study , 1999, European Journal of Nuclear Medicine.
[8] L. Wartofsky. Management of Patients with Scan Negative, Thyroglobulin Positive Differentiated Thyroid Carcinoma , 1998 .
[9] N. D. Charkes,et al. On the prevalence of familial nonmedullary thyroid cancer in multiply affected kindreds. , 2006, Thyroid : official journal of the American Thyroid Association.
[10] K. Schmiegelow,et al. Increased fluorine-18 2-fluoro-2-deoxy-D-glucose (FDG) uptake in childhood CNS tumors is correlated with malignancy grade: a study with FDG positron emission tomography/magnetic resonance imaging coregistration and image fusion. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] K. Burman. Micropapillary thyroid cancer: should we aspirate all nodules regardless of size? , 2006, The Journal of clinical endocrinology and metabolism.
[12] L. Wartofsky. Management of low-risk well-differentiated thyroid cancer based only on thyroglobulin measurement after recombinant human thyrotropin. , 2002, Thyroid : official journal of the American Thyroid Association.
[13] E. Mazzaferri,et al. Management of papillary and follicular (differentiated) thyroid cancer: new paradigms using recombinant human thyrotropin. , 2002, Endocrine-related cancer.
[14] P. Yeo,et al. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients. , 1997, The Journal of clinical endocrinology and metabolism.
[15] Gerard M Doherty,et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. , 2006, Thyroid : official journal of the American Thyroid Association.
[16] P. Schnyder,et al. The value of PET, CT and in-line PET/CT in patients with gastrointestinal stromal tumours: long-term outcome of treatment with imatinib mesylate , 2004, European Journal of Nuclear Medicine and Molecular Imaging.
[17] S. Prato. Tackling hyperglycemia: a more comprehensive approach. , 2006 .
[18] Stephanie L. Lee,et al. A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. , 2003, The Journal of clinical endocrinology and metabolism.
[19] J. Weissman,et al. MRI Detection of Cervical Metastasis From Differentiated Thyroid Carcinoma , 2001, The Laryngoscope.
[20] H. Schöder,et al. Positron emission imaging of head and neck cancer, including thyroid carcinoma. , 2004, Seminars in nuclear medicine.
[21] P. Som,et al. Detection of metastasis in cervical lymph nodes: CT and MR criteria and differential diagnosis. , 1992, AJR. American journal of roentgenology.
[22] P. Ladenson,et al. The role of PET in follow-up of patients treated for differentiated epithelial thyroid cancers , 2007, Nature Clinical Practice Endocrinology &Metabolism.
[23] G. V. von Schulthess,et al. Why most PET of lung and head-and-neck cancer will be PET/CT. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[24] P. Ladenson,et al. Prospective multicenter study of thyroid carcinoma treatment , 1998 .
[25] David Goldenberg,et al. The Role of Positron Emission Tomography/Computed Tomography in the Management of Recurrent Papillary Thyroid Carcinoma , 2005, The Laryngoscope.
[26] M. Ringel,et al. Papillary and follicular variant of papillary carcinoma of the thyroid: Initial presentation and response to therapy , 2005, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[27] Carmen C. Solorzano,et al. Thyroid Cancer: Is the Incidence Still Increasing? , 2004, Annals of Surgical Oncology.
[28] R. Jeffrey,et al. Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement. , 2005, Ultrasound quarterly.
[29] E. Wardelmann,et al. Integrated PET/CT in differentiated thyroid cancer: diagnostic accuracy and impact on patient management. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.